Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.4x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -53.76% |
| 2023 | -22.04% |
| 2022 | 2.99% |
| 2021 | 10.93% |
| 2020 | -17.74% |
| 2019 | 151.51% |
| 2018 | 198.95% |
| 2017 | 0.00% |